A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy

H Omuya, C Nickel, P Wilson… - International Journal of …, 2023 - academic.oup.com
Background Mixed findings about deprescribing impact have emerged from varied study
designs, interventions, outcome measures and targeting sub-categories of medications or …

Optimizing treatment for older adults with depression

M Srifuengfung, BRT Pennington… - Therapeutic Advances …, 2023 - journals.sagepub.com
This review presents a comprehensive guide for optimizing medication management in
older adults with depression within an outpatient setting. Medication optimization involves …

[HTML][HTML] Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an …

J Brandt, J Bressi, ML Lê, D Neal, C Cadogan… - …, 2024 - thelancet.com
Background Clinical practice guidelines and guidance documents routinely offer prescribing
clinicians' recommendations and instruction on the use of psychotropic drugs for mental …

Clinical decision‐making in benzodiazepine deprescribing by healthcare providers vs. AI‐assisted approach

I Bužančić, D Belec, M Držaić, I Kummer… - British journal of …, 2024 - Wiley Online Library
Aims The aim of this study was to compare the clinical decision‐making for benzodiazepine
deprescribing between a healthcare provider (HCP) and an artificial intelligence (AI) chatbot …

[HTML][HTML] Adaptation and validation of the revised Patients' Attitudes towards Deprescribing (rPATD) questionnaire for benzodiazepine receptor agonists

C Pétein, A Spinewine, ML Laroche, A Niquille… - Research in Social and …, 2023 - Elsevier
Abstract Background The revised Patients' Attitudes Towards Deprescribing (rPATD)
questionnaire explores older adults' views on deprescribing in general. Those views may …

[HTML][HTML] Implementation of interprofessional quality circles on deprescribing in Swiss nursing homes: an observational study

S Mena, JC Moullin, M Schneider, A Niquille - BMC geriatrics, 2023 - Springer
Background Polypharmacy and potentially inappropriate medications (PIMs) are still
frequent among older adults in nursing homes. Deprescribing is an intervention that has …

Pharmacists' contribution to benzodiazepine deprescribing in older outpatients: a systematic review and meta-analysis

TAR Melo, CO Bezerra, BD Fernandes, I Rotta… - International Journal of …, 2023 - Springer
Background Consolidated and reliable evidence regarding the effectiveness of pharmacist
interventions for deprescribing benzodiazepines in older outpatients is lacking. Aim This …

Deprescribing in older adults with polypharmacy

A Hung, YH Kim, JM Pavon - bmj, 2024 - bmj.com
Polypharmacy is common in older adults and is associated with adverse drug events,
cognitive and functional impairment, increased healthcare costs, and increased risk of frailty …

[HTML][HTML] Multidisciplinary DEprescribing review for Frail oldER adults in long-term care (DEFERAL): Implementation strategy design using behaviour science tools and …

CH Heinrich, S McHugh, S McCarthy… - Research in Social and …, 2023 - Elsevier
Introduction Deprescribing is a strategy for reducing the use of potentially inappropriate
medications for older adults. Limited evidence exists on the development of strategies to …

Barriers and Enablers for Deprescribing glucose-lowering treatment in older adults: a Systematic review

M Mellot, L Jawal, T Morel, JP Fournier… - Journal of the American …, 2024 - Elsevier
Objectives Overtreatment with glucose-lowering treatment (GLT) is frequent and a source of
high morbidity and mortality in older adults with type 2 diabetes mellitus (T2DM). This study …